Cold Pain Therapeutics Market - Global Outlook and Forecast 2023-2028

Report ID: 1378043 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story

Cold therapy is also known as cryotherapy. It works by reducing blood flow to a particular area, which can significantly reduce inflammation and swelling that causes pain, especially around a joint or a tendon. It can temporarily reduce nerve activity, which can also relieve pain.
This report contains market size and forecasts of Cold Pain Therapeutics in Global, including the following market information:
Global Cold Pain Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cold Pain Therapeutics market was valued at 1942.9 million in 2021 and is projected to reach US$ 2502.9 million by 2028, at a CAGR of 3.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
OTC Products Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cold Pain Therapeutics include Sanofi, Pfizer, Hisamitsu Pharmaceutical, ROHTO Pharmaceutical, Beiersdorf, Johnson & Johnson, Medline Industries, Össur and Performance Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cold Pain Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cold Pain Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cold Pain Therapeutics Market Segment Percentages, by Type, 2021 (%)
OTC Products
Cold Packs
Cooling Towels
Prescription Products
Global Cold Pain Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cold Pain Therapeutics Market Segment Percentages, by Application, 2021 (%)
Musculoskeletal Disorders
Post-Operative Therapy
Sports Medicine
Post-Trauma Therapy
Global Cold Pain Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cold Pain Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cold Pain Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cold Pain Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Pfizer
Hisamitsu Pharmaceutical
ROHTO Pharmaceutical
Beiersdorf
Johnson & Johnson
Medline Industries
Össur
Performance Health
Breg
Romsons Group of Industries

Frequently Asked Questions
Cold Pain Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cold Pain Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cold Pain Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports